Upregulation of DDX11 was documented in lung adenocarcinoma (14), osteosarcoma (15), advanced melanoma (16), and HCC (17), which indicate that DDX11 may exert pro-tumor activity. This evidence concerns the gene DDX11 and neoplasm.